Free Trial

Telomir Pharmaceuticals (TELO) Institutional Ownership

Telomir Pharmaceuticals logo
$1.18 0.00 (0.00%)
Closing price 03:58 PM Eastern
Extended Trading
$1.18 0.00 (0.00%)
As of 04:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Telomir Pharmaceuticals (NASDAQ:TELO)

Number of
Institutional Buyers
(last 12 months)
20
Total
Institutional Inflows
(last 12 months)
$4.13M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$117.88K
Get TELO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Telomir Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

TELO Institutional Buying and Selling by Quarter

Telomir Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/27/2025Goldman Sachs Group Inc.32,282$104K0.0%-36.1%0.108%
5/16/2025Goldman Sachs Group Inc.32,282$104K0.0%-36.1%0.108%
5/13/2025HighTower Advisors LLC43,000$139K0.0%N/A0.144%
5/12/2025Nuveen LLC24,990$81K0.0%N/A0.084%
4/29/2025Bank of New York Mellon Corp91,353$295K0.0%+26.4%0.307%
2/17/2025Nuveen Asset Management LLC24,990$103K0.0%N/A0.084%
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.10,699$44K0.0%+279.4%0.036%
2/17/2025Gotham Asset Management LLC6,770$28K0.0%N/A0.023%
2/17/2025Bank of America Corp DE14,713$61K0.0%+283.9%0.049%
2/14/2025Northern Trust Corp151,628$625K0.0%+211.5%0.510%
2/14/2025Transce3nd LLC28,803$119K0.0%N/A0.097%
2/13/2025Barclays PLC29,959$123K0.0%+326.9%0.101%
2/13/2025Wells Fargo & Company MN10,044$41K0.0%+458.3%0.034%
2/12/2025Geode Capital Management LLC413,677$1.71M0.0%+73.3%1.390%
2/12/2025JPMorgan Chase & Co.41,444$171K0.0%+1,096.4%0.139%
2/11/2025Corebridge Financial Inc.9,613$40K0.0%+273.8%0.032%
2/11/2025Virtu Financial LLC14,959$62K0.0%N/A0.050%
2/6/2025Charles Schwab Investment Management Inc.46,406$191K0.0%+327.7%0.157%
2/4/2025Bank of New York Mellon Corp72,295$298K0.0%+40.8%0.244%
1/30/2025Rhumbline Advisers8,600$35K0.0%+105.9%0.029%
11/19/2024Barclays PLC7,018$45K0.0%+325.1%0.024%
11/16/2024Geode Capital Management LLC238,737$1.53M0.0%+259.8%0.806%
11/15/2024Barclays PLC7,018$45K0.0%+325.1%0.024%
11/15/2024State Street Corp36,094$232K0.0%+99.1%0.122%
10/21/2024Suncoast Equity Management51,194$329K0.0%+109.9%0.173%
8/15/2024Beaird Harris Wealth Management LLC14,623$70K0.0%+212.9%0.049%
7/26/2024Bank of New York Mellon Corp50,165$241K0.0%N/A0.169%
5/2/2024Suncoast Equity Management24,391$126K0.0%N/A0.082%
(Data available from 1/1/2016 forward)

TELO Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of TELO shares?

During the previous two years, 21 institutional investors and hedge funds held shares of Telomir Pharmaceuticals. The most heavily invested institutionals were Geode Capital Management LLC ($1.71M), Northern Trust Corp ($625K), Suncoast Equity Management ($329K), Bank of New York Mellon Corp ($295K), State Street Corp ($232K), Charles Schwab Investment Management Inc. ($191K), and JPMorgan Chase & Co. ($171K).Learn more on Telomir Pharmaceuticals' institutional investors.

Which institutional investors have been buying Telomir Pharmaceuticals' stock?

Of the 20 institutional investors that purchased Telomir Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Geode Capital Management LLC ($347.32K), Northern Trust Corp ($102.95K), Bank of New York Mellon Corp ($90.15K), Suncoast Equity Management ($51.19K), HighTower Advisors LLC ($43K), JPMorgan Chase & Co. ($37.98K), and Charles Schwab Investment Management Inc. ($35.56K).

How much institutional buying is happening at Telomir Pharmaceuticals?

Institutional investors have bought a total of 884,336 shares in the last 24 months. This purchase volume represents approximately $4.13M in transactions.

Which of Telomir Pharmaceuticals' major shareholders have been selling company stock?

The following institutional investors have sold Telomir Pharmaceuticals stock in the last 24 months: Goldman Sachs Group Inc. ($36.50K).

How much institutional selling is happening at Telomir Pharmaceuticals?

Institutional investors have sold a total of 36,496 shares in the last 24 months. This volume of shares sold represents approximately $117.88K in transactions.



This page (NASDAQ:TELO) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners